Search

Your search keyword '"Le Cesne, A."' showing total 2,947 results

Search Constraints

Start Over You searched for: Author "Le Cesne, A." Remove constraint Author: "Le Cesne, A."
2,947 results on '"Le Cesne, A."'

Search Results

1. Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

3. Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study

6. Why cave planthoppers study matters: are Cixiidae a subtroglophile lineage? (Hemiptera, Fulgoromorpha)

7. Malagasy spittlebugs (Hemiptera: Cercopidae), a taxonomic review of genera from Madagascar

8. Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

9. Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma

10. Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

11. Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs

12. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

14. Improved nationwide survival of sarcoma patients with a network of reference centers

16. A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

17. Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years

19. Prognostic factors of the synovial sarcoma of the extremities: imaging does matter

20. Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF)

21. Leiomyosarcoma and liposarcoma in young patients: The national netsarc+ network experience

22. Leiomyosarcoma and liposarcoma in young patients: The national netsarc+ network experience

24. Single‐agent gemcitabine in patients with advanced, pre‐treated angiosarcoma: A multicenter, retrospective study

25. Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years

26. Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study

27. Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial

28. Overview of the role of liquid biopsy in cancer management

33. Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC

36. Desmoid type fibromatosis in pediatric and young adults from French databases: Clinical characteristics and initial outcome according to age

37. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response

39. VP3-2024: A randomized study of 6 vs 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

40. Coframalaxius bletteryi gen. et sp. nov. from subterranean habitat in Southern France (Hemiptera, Fulgoromorpha, Cixiidae, Oecleini)

42. Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours: Long-term follow-up of nilotinib in TGCT

43. Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses

46. Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)

48. Desmoid type fibromatosis in pediatric and young adults from French databases: Clinical characteristics and initial outcome according to age

49. Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome

Catalog

Books, media, physical & digital resources